MBS2123894 | Recombinant Von Hippel Lindau Tumor Suppressor (vHL)

Recombinant Von Hippel Lindau Tumor Suppressor (vHL) | MBS2123894 | Mybiosource

Product Short Name: [Von Hippel Lindau Tumor Suppressor]

Product Name Synonyme: [HRCA1; RCA1; VHL1; Von Hippel-Lindau Syndrome]

Other Names: [fibroblast growth factor 3; Fibroblast growth factor 3; fibroblast growth factor 3; fibroblast growth factor 3; Heparin-binding growth factor 3; HBGF-3; Proto-oncogene Int-2]

Product Gene Name: [vHL]

Product Gene Name Synonyme: N/A

Other Gene Names: [FGF3; FGF3; INT2; HBGF-3; INT2; FGF-3; HBGF-3]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: E Coli

Reactivity: N/A

Specificity: N/A

Purity: >80%

Form: Freeze-dried powder
20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.

Concentration: N/A

Storage Stability: Store at 2-8 degree C for one month. Aliquot and store at -80 degree C for 12 months. Avoid repeated freeze/thaw cycles.
Stability: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Tested Application: Positive Control, Immunogen, SDS-PAGE, Western Blot (WB)